JEANNA BURKE: Open Payments
NPI 1316599681 · SPARKS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$578 in 28 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $554 · 2025 $578
Food & beverage: $578
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 8 | $181 |
| PFIZER INC. | 4 | $68 |
| Merck Sharp & Dohme LLC | 3 | $56 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $46 |
| Actelion Pharmaceuticals US, Inc. | 1 | $37 |
| Lilly USA, LLC | 2 | $35 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $32 |
| Otsuka America Pharmaceutical, Inc. | 1 | $28 |
| Agios Pharmaceuticals, Inc. | 1 | $23 |
| Medtronic, Inc. | 1 | $22 |
Products named: KRYSTEXXA, NURTEC ODT, Kerendia, ROTATEQ, OPSUMIT, MOUNJARO, CAPLYTA, OTEZLA.
Industry payments across NV — which companies pay providers there.
